Preparation of albendazole polybutycyanocrylate nanoparticles and study on its pharmaceutical properties and tissue distribution

Yaoxue Xuebao

Volumn 38, Issue 6, 2003, Pages 462-466

  Zhang, Xue Nong ^a   Zhang, Qiang ^a   Wen, Hao ^b   Wang, Guo Quan ^b   Sun, Dian Jia ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Albendazole; Bioavailability; Nanoparticles; Plasm protein binding rate; Tissue distribution

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; DRUG CARRIER; ENBUCRILATE;

ANIMAL; ARTICLE; BIOAVAILABILITY; CHEMISTRY; DRUG DELIVERY SYSTEM; FEMALE; LIVER; MALE; METABOLISM; METHODOLOGY; MOUSE; NANOTECHNOLOGY; PARTICLE SIZE; PHARMACEUTICS; SPLEEN; TISSUE DISTRIBUTION;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENBUCRILATE; FEMALE; LIVER; MALE; MICE; NANOTECHNOLOGY; PARTICLE SIZE; SPLEEN; TECHNOLOGY, PHARMACEUTICAL; TISSUE DISTRIBUTION;

EID: 3442882900     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Mohamed AE, Yasawy MI, Al Karawi MA. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease [J]. Hepatogastroenterology, 1998, 45(23):1690-694.
2. Venkatesan P. Albendazole [J]. J Antimicrob Chemother, 1998, 41(2):145-147.
3. Arshady R. In vivo targeting of colloidal carriers by novel graft copolymers [J]. J Mol Recognit, 1996, 9(5-6):536-542.
4. Zhang ZR, Lu W. Study on liver targeting and sustained release hydroxycamptothecin polybutylcyanoacrylate nanoparticles [J]. Acta Pharm Sin, 1997, 32(3):222-227.
5. Gessner A, Waicz R, Lieske A, et al. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption [J]. Int J Pharm, 2000, 196(2):245-249.
6. Zhang XN, Miao ED, WANG GQ, et al. The preparation and release kinetics of albendazole nonaparticles [J]. Chin J Mod Appl Pharm, 2002, 19(2):114-117.
7. Qi XR, Maitani Y, Hou XP, et al. Interactions of insulin with dipalmitoylphosphatidylcholine lipsome [J]. Acta Pharm Sin, 2000, 35(12):924-928.
8. Hou XP. Physichemistry [M]. Vol 4. Beijing: People's Medical Publishing House, 2000. 286-293.
9. Walk JL. Effects of localized pasteurella haemolytica infection on erythromycin-bindiing properties of bovine alpha-1-acid glycoprotein, albumin, serum, and tissues chamber fluids [J]. Antimicrob Agents Chemother, 1994, 38(10):2392-2395.
10. Oksanen CA, Zografi G. Molecular mobility in mixtures of absorbed water and solid poly (vinylpyrrolidone) [J]. Pharm Res, 1993, 10(6):791-799.
11. Lück M, Paulke BR, Schröder W, et al. Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics [J]. J Biomed Mater Res, 1998, 39(3):478-485.